The Use of Hyaluronan After Arthroscopic Surgery of the Knee

Arthroscopy - Journal of Arthroscopic and Related Surgery

Volumn 26, Issue 1, 2010, Pages 105-111

  Waddell, David D ^a   Bert, Jack M ^b,c  

^a Orthopedic Specialists of Louisiana   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c Summit Orthopedics Ltd Minnesota   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ARTZAL; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; HYALURONIC ACID; HYLAN G F 20; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; STEROID; UNCLASSIFIED DRUG; VISCOSEAL;

ABSENCE OF SIDE EFFECTS; ANALGESIA; ARTHROSCOPIC DEBRIDEMENT; ARTHROSCOPIC SURGERY; CLINICAL TRIAL; CONSERVATIVE TREATMENT; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; ELBOW DISEASE; HIP OSTEOARTHRITIS; HUMAN; JOINT SWELLING; KNEE ARTHROSCOPY; KNEE OSTEOARTHRITIS; KNEE PAIN; MENISCECTOMY; PHYSIOTHERAPY; POSTOPERATIVE CARE; REVIEW; SHOULDER DISEASE; SPINE DISEASE; TOTAL KNEE REPLACEMENT; TREATMENT RESPONSE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHROSCOPY; COMBINED MODALITY THERAPY; DEBRIDEMENT; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; KNEE JOINT; MATRIX METALLOPROTEINASES; MENISCI, TIBIAL; MULTICENTER STUDIES AS TOPIC; NOCICEPTORS; OSTEOARTHRITIS, KNEE; POSTOPERATIVE CARE; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VISCOSUPPLEMENTS;

EID: 72649097373     PISSN: 07498063     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arthro.2009.05.009     Document Type: Review

References (57)

1. Centers for Disease Control and Prevention. Prevalence of disabilities and associated health conditions among adults-United States, 1999. MMWR Morb Mortal Wkly Rep 50 (2001) 120-125
2. WHO Scientific Group. The burden of musculoskeletal conditions at the start of the new millennium. World Health Organ Tech Rep Ser 919 (2003) i-ix, 1-218, back cover
3. Synvisc (hylan G-F 20) [product information] (2006), Genzyme Biosurgery, Cambridge, MA
4. Hyalgan [prescribing information] (2007), Sanofi-aventis US LLC, Bridgewater, NJ
5. Supartz [product information] (2007), Seikagaku, Tokyo, Japan
6. Orthovisc (sodium hyaluronate) [product information] (2005), Anika Therapeutics, Woburn, MA
7. Euflexxa [prescribing information] (2006), Ferring Pharmaceuticals, Saint-Prex, Switzerland
8. American Academy of Orthopaedic Surgeons. Treatment of osteoarthritis of the knee (non-arthroplasty): Complete guideline (2008), American Academy of Orthopaedic Surgeons, Rosemont, IL
9. Wobig M., Dickhut A., Maier R., and Vetter G. Viscosupplementation with hylan G-F 20: A 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther 20 (1998) 410-423
10. Scale D., Wobig M., and Wolpert W. Viscosupplementation of osteoarthritic knees with hylan: A treatment schedule study. Curr Ther Res 55 (1994) 220-232
11. Altman R.D., and Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: A randomized clinical trial. Hyalgan Study Group. J Rheumatol 25 (1998) 2203-2212
12. Carrabba M.P., Paresce E., Angelini M., Re K.A., Torchiana E.E.M., and Perbellini A. The safety and efficacy of different dose schedules of hyaluronic acid in the treatment of painful osteoarthritis of the knee with joint effusion. Eur J Rheumatol Inflamm 15 (1995) 25-31
13. Grecomoro G., Martorana U., and Di Marco C. Intra-articular treatment with sodium hyaluronate in gonarthrosis: A controlled clinical trial versus placebo. Pharmatherapeutica 5 (1987) 137-141
14. Huskisson E.C., and Donnelly S. Hyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology 38 (1999) 602-607
15. Dougados M., Nguyen M., Listrat V., and Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: A 1 year placebo-controlled trial. Osteoarthritis Cartilage 1 (1993) 97-103
16. Raman R., Dutta A., Day N., Sharma H.K., Shaw C.J., and Johnson G.V. Efficacy of Hylan G-F 20 and sodium hyaluronate in the treatment of osteoarthritis of the knee-A prospective randomized clinical trial. Knee 15 (2008) 318-324
17. Kemper F., Gebhardt U., Meng T., and Murray C. Tolerability and short-term effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice. Curr Med Res Opin 21 (2005) 1261-1269
18. Kahan A., Lleu P.L., and Salin L. Prospective randomized study comparing the medico-economic benefits of hylan G-F 20 vs. conventional treatment in knee osteoarthritis. Joint Bone Spine 70 (2003) 276-281
19. Raynauld J.P., Torrance G., Band P., et al. A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (part 1 of 2): Clinical results. Osteoarthritis Cartilage 10 (2002) 506-517
20. Clarke S., Lock V., Duddy J., Sharif M., Newman J.H., and Kirwan J.R. Intra-articular hylan G-F 20 (Synvisc) in the management of patellofemoral osteoarthritis of the knee (POAK). Knee 12 (2005) 57-62
21. Caborn D., Rush J., Lanzer W., Parenti D., and Murray C. A randomized, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee. J Rheumatol 31 (2004) 333-343
22. Lussier A., Cividino A.A., McFarlane C.A., Olszynski W.P., Potashner W.J., and De Medicis R. Viscosupplementation with hylan for the treatment of osteoarthritis: Findings from clinical practice in Canada. J Rheumatol 23 (1996) 1579-1585
23. Wobig M., Beks P., Dickhut A., Maier R., and Vetter G. Open-label multicenter trial of the safety and efficacy of viscosupplementation with hylan G-F 20 (Synvisc) in primary osteoarthritis of the knee. J Clin Rheumatol 5 (1999) S24-S31
24. Evanich J.D., Evanich C.J., Wright M.B., and Rydlewicz J.A. Efficacy of intraarticular hyaluronic acid injections in knee osteoarthritis. Clin Orthop Relat Res 390 (2001) 173-181
25. Waddell D.D., and Bricker D. Clinical experience with the effectiveness and tolerability of hylan G-F 20 in 1047 patients with osteoarthritis of the knee. J Knee Surg 19 (2006) 19-27
26. Neustadt D.H. Long-term efficacy and safety of intra-articular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee. Clin Exp Rheumatol 21 (2003) 307-311
27. Kirchner M., and Marshall D. A double-blind randomized controlled trial comparing alternate forms of high molecular weight hyaluronan for the treatment of osteoarthritis of the knee. Osteoarthritis Cartilage (2006) 154-162
28. Bellamy N., Campbell J., Robinson V., Gee T., Bourne R., and Wells G. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2 (2006) CD005321
29. Wang C.T., Lin J., Chang C.J., Lin Y.T., and Hou S.M. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am 86 (2004) 538-545
30. Lo G.H., LaValley M., McAlindon T., and Felson D.T. Intra-articular hyaluronic acid in treatment of knee osteoarthritis. A meta-analysis. JAMA 290 (2004) 3115-3121
31. Belmonte C., Pozo M.A., and Balazs E.A. Modulation by hyaluronan and its derivatives (hylans) of sensory nerve activity signaling articular pain. In: Laurent T. (Ed). Chemistry, biology and medical applications of hyaluronan and its derivatives (1998), Portland Press, London 205-217 Proceedings of the Wenner-Gren Foundation International Symposium
32. Moore A.R., and Willoughby D.A. Hyaluronan as a drug delivery system for diclofenac: A hypothesis for mode of action. Int J Tissue React 17 (1995) 153-156
33. Bagga H., Burkhardt D., Sambrook P., and March L. Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee. J Rheumatol 33 (2006) 946-950
34. Waddell D.D., Cefalu C.A., and Bricker D.C. An open-label study of a second course of hylan G-F 20 for the treatment of pain associated with knee osteoarthritis. Curr Med Res Opin 19 (2003) 499-507
35. Marino A.A., Waddell D.D., Kolomytkin O.V., et al. Increased intercellular communication through gap junctions may contribute to progression of osteoarthritis. Clin Orthop Relat Res 422 (2004) 224-232
36. Kolomytkin O.V., Marino A.A., Waddell D.D., et al. IL-1β-induced production of metalloproteinases by synovial cells depends on gap junction conductance. Am J Physiol Cell Physiol 282 (2002) C1254-C1260
37. Garrett Jr. W.E., Swiontkowski M.F., Weinstein J.N., et al. American Board of Orthopaedic Surgery Practice of the Orthopaedic Surgeon: Part-II, certification examination case mix. J Bone Joint Surg Am 88 (2006) 660-667
38. Creamer P., and Hochberg M.C. Osteoarthritis. Lancet 350 (1997) 503-508
39. Moseley J.B., O'Malley K., Petersen N.J., et al. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med 347 (2002) 81-88
40. Dervin G., Stiell I., Rody K., and Grabowski J. The effect of arthroscopic debridement for osteoarthritis of the knee on health-related quality of life. J Bone Joint Surg Am 85 (2003) 10-19
41. Bhattacharyya T., Gale D., Dewire P., et al. The clinical importance of meniscal tears demonstrated by magnetic resonance imaging in osteoarthritis of the knee. J Bone Joint Surg Am 85 (2003) 4-9
42. Matsusue Y., and Thomson N.L. Arthroscopic partial medial meniscectomy in patients over 40 years old: A 5- to 11-year follow-up study. Arthroscopy 12 (1996) 39-44
43. Bin S.I., Lee S.H., Kim C.W., Kim T.H., and Lee D.H. Results of arthroscopic medial meniscectomy in patients with grade IV osteoarthritis of the medial compartment. Arthroscopy 24 (2008) 264-268
44. Outerbridge R. The etiology of chondromalacia of the patella. J Bone Joint Surg Br 42 (1961) 752-760
45. Marshall D., Johnell O., and Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312 (1996) 1254-1259
46. Chen Y., Peng D., Sun C.J., Wang W.C., Li J.Y., and Zhang W. Clinical study on sodium hyaluronate intra-articular injection in treatment of degenerative osteoarthritis of knee. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 16 (2002) 19-20 (in Chinese)
47. Dai G.F., Tang J.W., Wang S.J., Liu Q., and Shi D.P. Efficacy of intra-articular injection of sodium hyaluronate in post-operation treatment of the knee. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 16 (2002) 16-18 (in Chinese)
48. Rolf C.G., Engstrom B., Öhrvik J., Valentin A., Lija B., and Levin D.W. A comparative study of the efficacy and safety of hyaluronan viscosupplements and placebo in patients with symptomatic and arthroscopy-verified cartilage pathology. J Clin Res 8 (2005) 15-32
49. Mathies B. Effects of Viscoseal, a synovial fluid substitute, on recovery after arthroscopic partial meniscectomy and joint lavage. Knee Surg Sports Traumatol Arthrosc 14 (2006) 32-39
50. Hempfling H. Intra-articular hyaluronic acid after knee arthroscopy: A two-year study. Knee Surg Sports Traumatol Arthrosc 15 (2007) 537-546
51. Ulucay C., Altintas F., Ugutmen E., and Beksac B. The use of arthroscopic debridement and viscosupplementation in knee osteoarthritis. Acta Orthop Traumatol Turc 41 (2007) 337-342
52. Huang M.H., Yang R.C., and Chou P.H. Preliminary effects of hyaluronic acid on early rehabilitation of patients with isolated anterior cruciate ligament reconstruction. Clin J Sport Med 17 (2007) 242-250
53. Zietz P.M., and Selesnick H. The use of hylan G-F 20 after knee arthroscopy in an active patient population with knee osteoarthritis. Arthroscopy 24 (2008) 416-422
54. Huskin J.P., Vandekerckhove B., Delince P., et al. Multicentre, prospective, open study to evaluate the safety and efficacy of hylan G-F 20 in knee osteoarthritis subjects presenting with pain following arthroscopic meniscectomy. Knee Surg Sports Traumatol Arthrosc 16 (2008) 747-752
55. Mandelbaum B., and Waddell D. Etiology and pathophysiology of osteoarthritis. Orthopedics 28 Suppl (2005) s207-s214
56. Ahlback S. Osteoarthrosis of the knee. A radiographic investigation [thesis]. Stockholm: Karolinska Institute (1968) 11-15
57. Kellgren J., and Lawrence J. Radiologic assessment of osteoarthritis. Ann Rheum Dis 16 (1957) 494-501